Inventor · disambiguated record
Brian E. Fink
Also filed as: FINK BRIAN E · FINK BRIAN EDWARD
42 granted patents·15 pending applications·258 citations·filing 2003–2025
97Inventor score
Top patents by PatentIndex Score
57 records- 0194US9273057B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·29 cites·15 claims
- 0294US6916815B2C-6 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jul 12, 2005·55 cites·10 claims
- 0392US9273014B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 1, 2016·14 cites·11 claims
- 0492US7605160B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 20, 2009·28 cites·11 claims
- 0590US7148220B2C-6 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 12, 2006·13 cites·3 claims
- 0689US8252795B2Imidazopyridazinecarbonitriles useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Aug 28, 2012·19 cites·11 claims
- 0789US7531539B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 12, 2009·18 cites·10 claims
- 0889US7297695B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 20, 2007·9 cites·4 claims
- 0986US8999918B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 7, 2015·9 cites·19 claims
- 1083US9708316B2TGFβR antagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 18, 2017·5 cites·13 claims
- 1183US9273075B2Prodrugs of 1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·4 cites·9 claims
- 1282US11427610B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 30, 2022·2 cites·23 claims
- 1382US10953032B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 23, 2021·2 cites·20 claims
- 1481US10947263B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 16, 2021·2 cites·21 claims
- 1581US9133139B2Fluoroalkyl-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 15, 2015·2 cites·10 claims
- 1681US7417040B2Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3BRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·3 cites·13 claims
- 1779US9556178B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 31, 2017·3 cites·7 claims
- 1879US8940736B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 27, 2015·3 cites·19 claims
- 1978US7776859B2Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Aug 17, 2010·2 cites·17 claims
- 2078US7514435B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 7, 2009·3 cites·6 claims
- 2178US7378426B2Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3BRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 27, 2008·2 cites·30 claims
- 2278US7141571B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·8 cites·4 claims
- 2377US11660311B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 30, 2023·2 cites·17 claims
- 2477US8791257B2Substituted pyrrolotriazines as protein kinase inhibitorsMARKWALDER JAY A·Filed 2011·Granted Jul 29, 2014·6 cites·13 claims
- 2577US7064203B2Di-substituted pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jun 20, 2006·9 cites·6 claims
- 2676US7846931B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Dec 7, 2010·1 cites·1 claims
- 2776US2025163046A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2876US2025154148A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2975US7982033B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jul 19, 2011·2 cites·4 claims
- 3073US10292985B2TGF beta receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 21, 2019·1 cites·12 claims
- 3169US8389527B2Substituted imidazopyridazines useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Mar 5, 2013·1 cites·12 claims
- 3268US2025250271A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3366US10336761B2TGFβ receptor antagonistBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 2, 2019·1 cites·6 claims
- 3465US2025353844A1Tetrahydropyrido 3,4-d pyrimidine derivatives as kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3565US2025263424A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3664US2024199584A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3762US8148523B2Intermediates useful in preparing certain pyrrolotriazine compounds and a process for making the intermediatesFINK BRIAN E·Filed 2008·Granted Apr 3, 2012·0 cites·5 claims
- 3861US11339185B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted May 24, 2022·0 cites·11 claims
- 3958US10519187B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 31, 2019·0 cites·70 claims
- 4058US2024217982A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4158US2024317769A1Kras g12d inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4257US9371328B2Imidazopyridazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 21, 2016·0 cites·8 claims
- 4356US12012374B2Agonists of ROR GAMMAtBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 18, 2024·0 cites·10 claims
- 4455US2024109899A1Benzofuran compounds as sting agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4554US2011039838A1Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 4653US2016108050A1Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4752US11945834B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 2, 2024·0 cites·16 claims
- 4851US9242941B2Alkyl, fluoroalkyl-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·0 cites·8 claims
- 4951US2012283241A1Imidazopyridazinecarbonitriles useful as kinase inhibitorsFINK BRIAN E·Filed 2012·Application pending·0 cites
- 5050US2023295087A1AGONISTS OF ROR GAMMAtBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →